Product Program year 2024 Source: CMS Open Payments

Alyglo

Drug Immunology

NDC 61476-104-20

Open in the dashboard

General payments

$8,134

158 payments

Research payments

$0

0 payments

Through program year 2024, $8,134 in general payments and $0 in research payments were reported against Alyglo (Immunology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2024 General $8,134 158

Breakdown

Who paid General payments · program year 2024
  1. GC Biopharma USA, Inc. $8,134 158 payments
Top recipients General payments · program year 2024
  1. Raffi Tachdjian Allergy & Immunology · Santa Monica, CA $5,000 61% · 1 payment
  2. Todd Hrabak Allergy · Glendale, AZ $58 <1% · 3 payments
  3. Michael Polcari Allergy & Immunology · Birmingham, AL $45 <1% · 2 payments
  4. Duane Wong Allergy & Immunology · Chandler, AZ $43 <1% · 3 payments
  5. Ryan Casper Allergy & Immunology · Peoria, AZ $42 <1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Allergy & Immunology $6,802 85% · 82 practitioners
  2. Allergy Allergy & Immunology $367 5% · 15 practitioners
  3. Physician Assistant $282 4% · 12 practitioners
  4. Allergy & Immunology Internal Medicine $132 2% · 8 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $130 2% · 6 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $5,152 63% · 8 recipients
  2. Texas $671 8% · 28 recipients
  3. Arizona $459 6% · 20 recipients
  4. Massachusetts $353 4% · 15 recipients
  5. South Carolina $221 3% · 10 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

158 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record